IRADIMED CORPORATION IRMD

Set alert

Price alert · IRMD

All alert types
79.42 USD +2.74 +3.57%

At close

80.50 +1.08 +1.36%

Pre-market · Nov 3, 7:07 AM ET

Bid
79.32 × 1
Ask
79.40 × 2
77.56 Day range 80.02
76.35 52-week range 107.90
YTD
-18.36%
1 year
-5.58%
Open
77.57
Prev close
76.68
Mkt cap
1.02B
Vol
203.50K
Avg vol
122.29K
EPS
1.87
P/E
42.47
Div yield
0.93%
More statistics
Low
77.56
High
80.02
Forward P/E
32.64
Beta
0.94
Short ratio
5.23
Inst. own
62.70%
Dividend
0.80
Ex-div date
Aug 13, 2026
Earnings
Feb 9, 2027
50-d avg
85.66
200-d avg
92.54
1y target
118.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for IRMD has not been loaded yet. Try again in a moment.

Analyst view

Consensus: buy

Buy
Price target (mean) 118.00 +48.6% upside
Target (low)
116.00
Target (mean)
118.00
Target (high)
120.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 3
  • 1 month ago 3
  • 2 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

IRMD analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.630.61 – 0.660.54+16.7%26.23M+15.6%3
Next quarter0.580.57 – 0.590.49+18.4%25.00M+13.7%2
Current year2.112.09 – 2.161.93+9.5%92.07M+9.9%3
Next year2.452.40 – 2.542.11+16.1%104.10M+13.1%3

Upgrades and downgrades

The latest rating changes

IRMD analyst upgrades and downgrades
DateFirmActionFromTo
Sep 22, 2026NeedhamInitiated—Hold
Apr 2, 2026Freedom BrokerInitiated—Buy
Feb 14, 2025Roth MKMReiteratedBuyBuy
Aug 2, 2024Roth MKMMaintainedBuyBuy
Aug 2, 2021Roth CapitalMaintained—Buy
Jul 31, 2017Roth CapitalUpgradeNeutralBuy
Oct 5, 2016Roth CapitalDowngradeBuyNeutral
Apr 4, 2016Roth CapitalMaintained—Buy
Jun 16, 2015Roth CapitalMaintained—Buy
Aug 11, 2014Roth CapitalInitiated——